Company profile: Concept Life Sciences
1.1 - Company Overview
Company description
- Provider of scientific laboratory and consulting services, offering integrated drug discovery and development; molecular biology (gene expression analysis, transcriptomics, genetic modification); protein production; spatial and structural biology; ADME & DMPK assays; and analytical testing and environmental consulting for pharmaceutical, biotechnology, agrochemical, and environmental sectors.
Products and services
- Integrated Drug Discovery & Development: Delivers custom-engineered, comprehensive services spanning initial concept to clinical stages, integrating drug discovery and development activities tailored to the unique requirements of each drug
- ADME & DMPK: Offers industry-standard assays and studies evaluating absorption, distribution, metabolism, excretion, and toxicity of drug candidates to characterize ADME and DMPK properties during development
- Structural Biology: Engineers structure-guided elucidation of protein structures to aid in the design and optimization of drug candidates across discovery programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Concept Life Sciences
Regulatory Professionals
HQ: United States
Website
- Description: Provider of regulatory expertise and end-to-end development support to biotechnology, pharmaceutical and medical device companies, including strategic product development, regulatory strategy, submissions and meetings, clinical and PK design, CMC integration and vendor management, nonclinical strategy and studies, and commercial insights to maximize program potential from development through commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regulatory Professionals company profile →
Modality Solutions
HQ: United States
Website
- Description: Provider of package engineering and controlled-environment logistics solutions for highly regulated industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modality Solutions company profile →
Oncodesign
HQ: France
Website
- Description: Provider of precision medicine-driven oncology preclinical CRO services and biopharmaceutical R&D, developing anticancer therapies and leveraging platforms such as Nanocyclix for selective kinase inhibitors and OncoSNIPER AI for resistant patient stratification. Pipeline includes OPM-101 (RIPK2, IBD), OPM-102 (RIPK2, inflammation-related tumors), and an LRRK2 program (Parkinson’s), plus the IMODI cluster for cancer models and microbiota studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign company profile →
Organix
HQ: United States
Website
- Description: Provider of organic synthesis services across all areas of organic chemistry, partnering with biotech, pharmaceutical, and government clients. Offerings include custom synthesis (new chemical entities, phosphoramidites, drug conjugates), GMP-grade lipid synthesis, medicinal chemistry, contract R&D, analytical services (NMR, mass spectrometry), and polymer conjugates (PEG, HPMA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Organix company profile →
Quay Pharma
HQ: Australia
Website
- Description: Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quay Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Concept Life Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Concept Life Sciences
2.2 - Growth funds investing in similar companies to Concept Life Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Concept Life Sciences
4.2 - Public trading comparable groups for Concept Life Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →